Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-25-007313

EVP R&D, Chief Medical Officer gave up 3,049 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 6,866 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Exercise or conversion : show line 1 in the form +6,866 80,789 D
2025-02-26 Shares withheld for taxes : show line 2 in the form −3,049 $34.80 $106,090 77,740 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-26 Exercise or conversion : show line 3 in the form Restricted Stock Unit Award −6,866 20,598 D
Loading xslF345X05/form4.xml…